Organizations:
Emergent BioSolutions, Entos Pharmaceuticals, Government of Canada, Government of Manitoba, Health Canada, Moderna, Northern RNA, Pfizer-BioNTech, and Providence Therapeutics
People:
Brad Sorenson, François-Philippe Champagne, John Lewis, Premier Brian Pallister, Premier Jason Kenney, and Prime Minister Justin Trudeau
Topics:
clinical trials, COVID variants, COVID-19 pandemic, COVID-19 vaccines, DNA-based COVID-19 vaccine, domestic vaccine manufacturing capacity, federal support for Canadian vaccine developers, inter-provincial task force on domestic vaccine supply, made-in-Canada COVID-19 vaccines, mRNA vaccines, secure domestic vaccine supply, and vaccine components
Calgary vaccine developer reaches deal with Manitoba government after hearing no response from Ottawa
Mark LoweyFebruary 17, 2021
Providence Therapeutics, a Calgary biotechnology company in human trials with its COVID-19 vaccine, struck a supply deal with the Government of Manitoba after sending the federal government a proposal and receiving no response. In a video, Providence founder and CEO Brad Sorenson criticized Ottawa's "apathetic response" as "unacceptable" and he implored the government to take initiative to establish a secure domestic vaccine supply.
Other News
Events For Leaders in
Science, Tech, Innovation, and Policy
Discuss and learn from those in the know at our virtual and in-person events.
See Upcoming Events
You have 0 free articles remaining.
Don't miss out - start your free trial today.
Start your FREE trial Already a member? Log in
By using this website, you agree to our use of cookies. We use cookies to provide you with a great experience and to help our website run effectively in accordance with our Privacy Policy and Terms of Service.